- Home
- NGS vs BNTC Comparison
NGS vs BNTC Comparison
Compare NGS & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGS | BNTC |
|---|---|---|
| Founded | 1998 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.9M | 405.7M |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | NGS | BNTC |
|---|---|---|
| Price | $32.38 | $11.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $35.67 | $28.25 |
| AVG Volume (30 Days) | 93.7K | ★ 245.9K |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | ★ 1.39% | N/A |
| EPS Growth | ★ 14.85 | N/A |
| EPS | ★ 1.47 | N/A |
| Revenue | ★ $166,824,000.00 | N/A |
| Revenue This Year | $9.50 | N/A |
| Revenue Next Year | $13.88 | N/A |
| P/E Ratio | $21.60 | ★ N/A |
| Revenue Growth | ★ 9.53 | N/A |
| 52 Week Low | $16.73 | $9.70 |
| 52 Week High | $33.82 | $17.15 |
Technical Indicators
Market Signals| Indicator | NGS | BNTC |
|---|---|---|
| Relative Strength Index (RSI) | 56.97 | 39.57 |
| Support Level | $31.51 | $9.93 |
| Resistance Level | $33.15 | $12.99 |
| Average True Range (ATR) | 1.07 | 1.00 |
| MACD | -0.17 | -0.11 |
| Stochastic Oscillator | 54.27 | 41.60 |
Price Performance
Historical ComparisonAbout NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.